RRAM
HAE icon

River Road Asset Management’s Haemonetics HAE Stock Holding History

River Road Asset Management’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$96.4M Sell
1,285,602
-42,387
-3% -$2.72M 1.07% 29
2026
Q1 		$74.8M Buy
1,327,989
+225,849
+20% +$14.7M 0.85% 44
2025
Q4 		$88.3M Sell
1,102,140
-552,650
-33% -$37.1M 0.97% 35
2025
Q3 		$80.7M Sell
1,654,790
-886
-0.1% -$54.8K 0.9% 39
2025
Q2 		$123M Buy
1,655,676
+260,624
+19% +$17.3M 1.56% 16
2025
Q1 		$88.7M Buy
+1,395,052
New +$94.9M 1.21% 20
2022
Q4 		– Sell
-93,995
Closed -$6.96M – 176
2022
Q3 		$6.96M Sell
93,995
-374,660
-80% -$26.9M 0.1% 140
2022
Q2 		$30.5M Sell
468,655
-473,686
-50% -$28M 0.43% 75
2022
Q1 		$59.6M Buy
942,341
+146,641
+18% +$7.97M 0.66% 58
2021
Q4 		$42.2M Buy
795,700
+386,813
+95% +$23.6M 0.45% 69
2021
Q3 		$28.9M Buy
408,887
+116,271
+40% +$7.34M 0.32% 83
2021
Q2 		$19.5M Buy
+292,616
New +$20.7M 0.21% 108

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

River Road Asset Management's HAE Position: Q2 2026 in Review

River Road Asset Management reduced its Haemonetics (HAE) stake by 3.2% in Q2 2026, selling an estimated $2.72M and leaving 1,285,602 shares worth $96.4M. The position accounts for 1.07% of the portfolio, ranked #29.

River Road Asset Management first reported a position in HAE in Q2 2021 and has held it in 12 quarters since. The position peaked at $123M in Q2 2025. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • River Road Asset Management held 1,285,602 shares of Haemonetics worth $96.4M as of Q2 2026.
  • River Road Asset Management sold 42,387 Haemonetics shares in Q2 2026, an estimated $2.72M.
  • Haemonetics made up 1.07% of River Road Asset Management's portfolio in Q2 2026, its #29 holding.
  • River Road Asset Management first reported a position in Haemonetics in Q2 2021 and has held it in 12 quarters since.
  • River Road Asset Management's Haemonetics position peaked at $123M in Q2 2025.
  • 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on River Road Asset Management's 13F filing for Q2 2026, filed 17 Jul 2026.